Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 May;25(5):871-4.
doi: 10.1681/ASN.2014010062. Epub 2014 Mar 7.

HDL in CKD: how good is the "good cholesterol?"

Ian H de Boer  1 , John D Brunzell  2
Affiliations
Editorial

HDL in CKD: how good is the "good cholesterol?"

Ian H de Boer et al. J Am Soc Nephrol. 2014 May.
No abstract available

Keywords: HDL; cardiovascular; chronic kidney disease.

PubMed Disclaimer

Comment on

References

    1. Zewinger S, Speer T, Kleber ME, Scharnagl H, Woitas R, Lepper PM, Pfahler K, Seiler S, Heine GH, Marz W, Silbernagel G, Fliser D: HDL-cholesterol is not associated with lower mortality. J Am Soc Nephrol 25: 1073–1082, 2014 - PMC - PubMed
    1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62: 707–714, 1977 - PubMed
    1. Rye KA, Barter PJ: Cardioprotective functions of HDL. J Lipid Res 55: 168–179, 2014 - PMC - PubMed
    1. Brunzell JD, Zambon A, Deeb SS: The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta 1821: 365–372, 2012 - PMC - PubMed
    1. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators: Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357: 2109–2122, 2007 - PubMed

Substances